191 related articles for article (PubMed ID: 28271699)
21. Which cut-off value of serum anti-Müllerian hormone level can predict poor ovarian reserve, poor ovarian response to stimulation and in vitro fertilization success? A prospective data analysis.
Ficicioglu C; Cenksoy PO; Yildirim G; Kaspar C
Gynecol Endocrinol; 2014 May; 30(5):372-6. PubMed ID: 24576292
[TBL] [Abstract][Full Text] [Related]
22. Predictive factors for ovarian response in a corifollitropin alfa/GnRH antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles.
Oehninger S; Nelson SM; Verweij P; Stegmann BJ
Reprod Biol Endocrinol; 2015 Oct; 13():117. PubMed ID: 26520396
[TBL] [Abstract][Full Text] [Related]
23. Specific ranges of anti-Mullerian hormone and antral follicle count correlate to provide a prognostic indicator for IVF outcome.
Keane K; Cruzat VF; Wagle S; Chaudhary N; Newsholme P; Yovich J
Reprod Biol; 2017 Mar; 17(1):51-59. PubMed ID: 28132758
[TBL] [Abstract][Full Text] [Related]
24. The use of ovarian reserve markers in IVF clinical practice: a national consensus.
La Marca A; Ferraretti AP; Palermo R; Ubaldi FM
Gynecol Endocrinol; 2016; 32(1):1-5. PubMed ID: 26531067
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve.
Kwee J; Schats R; McDonnell J; Themmen A; de Jong F; Lambalk C
Fertil Steril; 2008 Sep; 90(3):737-43. PubMed ID: 17923131
[TBL] [Abstract][Full Text] [Related]
26. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.
Arce JC; La Marca A; Mirner Klein B; Nyboe Andersen A; Fleming R
Fertil Steril; 2013 May; 99(6):1644-53. PubMed ID: 23394782
[TBL] [Abstract][Full Text] [Related]
27. [Estimation of ovarian response using multiple predictors of ovarian reserve in women undergoing in vitro fertilization-embryo transfer].
He Y; Xia R; Chen X; Ye D; Tang Y; Li P; Niu J; Chen S
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):216-20. PubMed ID: 23443775
[TBL] [Abstract][Full Text] [Related]
28. Biomarkers of ovarian response: current and future applications.
Nelson SM
Fertil Steril; 2013 Mar; 99(4):963-9. PubMed ID: 23312225
[TBL] [Abstract][Full Text] [Related]
29. A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation.
Jayaprakasan K; Campbell B; Hopkisson J; Johnson I; Raine-Fenning N
Fertil Steril; 2010 Feb; 93(3):855-64. PubMed ID: 19046583
[TBL] [Abstract][Full Text] [Related]
30. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
[TBL] [Abstract][Full Text] [Related]
31. Ovarian response markers lead to appropriate and effective use of corifollitropin alpha in assisted reproduction.
La Marca A; D'Ippolito G
Reprod Biomed Online; 2014 Feb; 28(2):183-90. PubMed ID: 24368127
[TBL] [Abstract][Full Text] [Related]
32. Can highly sensitive antimüllerian hormone testing predict failed response to ovarian stimulation?
Burks HR; Ross L; Opper N; Paulson E; Stanczyk FZ; Chung K
Fertil Steril; 2015 Sep; 104(3):643-8. PubMed ID: 26158904
[TBL] [Abstract][Full Text] [Related]
33. Prospective analysis of ovarian reserve markers as determinant in response to controlled ovarian stimulation in women undergoing IVF cycles in low resource setting in India.
Singh N; Bahadur A; Malhotra N; Kalaivani M; Mittal S
Arch Gynecol Obstet; 2013 Sep; 288(3):697-703. PubMed ID: 23529683
[TBL] [Abstract][Full Text] [Related]
34. The dynamic changes of anti-Mullerian hormone and inhibin B during controlled ovarian hyperstimulation in decreased ovarian reserve women and the effect on clinical outcome.
Li Y; Nie M; Liu Y; Zhang W; Yang X
Gynecol Endocrinol; 2015 Jun; 31(6):450-3. PubMed ID: 25585549
[TBL] [Abstract][Full Text] [Related]
35. Possibilities and limits of ovarian reserve testing in ART.
La Marca A; Argento C; Sighinolfi G; Grisendi V; Carbone M; D'Ippolito G; Artenisio AC; Stabile G; Volpe A
Curr Pharm Biotechnol; 2012 Mar; 13(3):398-408. PubMed ID: 21657996
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population.
McIlveen M; Skull JD; Ledger WL
Hum Reprod; 2007 Mar; 22(3):778-85. PubMed ID: 17114197
[TBL] [Abstract][Full Text] [Related]
37. Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response.
Iliodromiti S; Anderson RA; Nelson SM
Hum Reprod Update; 2015; 21(6):698-710. PubMed ID: 25489055
[TBL] [Abstract][Full Text] [Related]
38. Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles.
La Marca A; Papaleo E; Grisendi V; Argento C; Giulini S; Volpe A
BJOG; 2012 Sep; 119(10):1171-9. PubMed ID: 22805536
[TBL] [Abstract][Full Text] [Related]
39. A novel mathematical model of true ovarian reserve assessment based on predicted probability of poor ovarian response: a retrospective cohort study.
Xu H; Feng G; Wang H; Han Y; Yang R; Song Y; Chen L; Shi L; Zhang MQ; Li R; Qiao J
J Assist Reprod Genet; 2020 Apr; 37(4):963-972. PubMed ID: 32318905
[TBL] [Abstract][Full Text] [Related]
40. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
Vuong TN; Phung HT; Ho MT
Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
